Evidence map›Paper›PMID 41667444›Full record

ArticleNature communications2026

Latent transition analysis for longitudinal studies of post-acute infection syndromes.

Roy Gusinow, Anna Górska, Lorenzo Maria Canziani, Iris Lopes-Rafegas, Carolina Alvarez Garavito, Adriana Tami, Elisa Gentilotti, Elisa Sicuri, Cédric Laouénan, Jade Ghosn and 14 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Roy GusinowThe Life and Medical Sciences Institute (LIMES), University of Bonn, Bonn, Germany.ORCID 0000-0002-0044-2613
Anna GórskaDivision of Infectious Diseases, Department of Diagnostics and Public Health, University of Verona, Verona, Italy.ORCID 0000-0003-3305-8711
Lorenzo Maria CanzianiDivision of Infectious Diseases, Department of Diagnostics and Public Health, University of Verona, Verona, Italy.ORCID 0000-0003-2537-5418
Iris Lopes-RafegasISGlobal, Barcelona, Spain.ORCID 0000-0003-2658-1432
Carolina Alvarez GaravitoThe Life and Medical Sciences Institute (LIMES), University of Bonn, Bonn, Germany.ORCID 0000-0002-4416-6980
Adriana TamiUniversity of Groningen, University Medical Center Groningen, Department of Medical Microbiology and Infection Prevention, Groningen, The Netherlands.ORCID 0000-0002-1918-9144
Elisa GentilottiDivision of Infectious Diseases, Department of Diagnostics and Public Health, University of Verona, Verona, Italy.
Elisa SicuriISGlobal, Barcelona, Spain.ORCID 0000-0002-2499-2732
Cédric LaouénanAPHP Nord, Hôpital Bichat, Service des Maladies Infectieuses, Paris, F75018, France.
Jade GhosnAPHP Nord, Hôpital Bichat, Service des Maladies Infectieuses, Paris, F75018, France.ORCID 0000-0003-2914-959X
Aline-Marie FlorenceAPHP Nord, Hôpital Bichat, Service des Maladies Infectieuses, Paris, F75018, France.
Nadhem LahfejAPHP Nord, Hôpital Bichat, Department of Epidemiology Biostatistics and Clinical Research, Paris, France.
Fulvia MazzaferriDivision of Infectious Diseases, Department of Diagnostics and Public Health, University of Verona, Verona, Italy.ORCID 0000-0002-3907-108X
Lidia Del PiccoloDepartment of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.ORCID 0000-0003-1735-9362
Maddalena GiannellaDepartment of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, Bologna, Italy.
Alice ToschiInfectious Diseases Unit, Department for Integrated Infectious Risk Management, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Michela Di ChiaraInfectious Diseases Unit, Department for Integrated Infectious Risk Management, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.ORCID 0009-0005-7101-7795
Maria Giulia CaponcelloUnidad Clnica de Enfermedades Infecciosas y Microbiologa, Hospital Universitario Virgen Macarena; Departamento de Medicina, Universidad de Sevilla, Instituto de Biomedicina de Sevilla (IBiS)/CSIC, Seville, Spain.
Zaira R Palacios-BaenaUnidad Clnica de Enfermedades Infecciosas y Microbiologa, Hospital Universitario Virgen Macarena; Departamento de Medicina, Universidad de Sevilla, Instituto de Biomedicina de Sevilla (IBiS)/CSIC, Seville, Spain.
Karin I WoldUniversity of Groningen, University Medical Center Groningen, Department of Medical Microbiology and Infection Prevention, Groningen, The Netherlands.ORCID 0000-0002-8750-7474
Elisa RossiCINECA Interuniversity Consortium, Bologna, Italy.
Evelina TacconelliDivision of Infectious Diseases, Department of Diagnostics and Public Health, University of Verona, Verona, Italy. evelina.tacconelli@univr.it.
Jan HasenauerThe Life and Medical Sciences Institute (LIMES), University of Bonn, Bonn, Germany. jan.hasenauer@uni-bonn.de.ORCID 0000-0002-4935-3312
ORCHESTRA study group

Funding

Deutsche Forschungsgemeinschaft (German Research Foundation) EXC 2047-390685813Deutsche Forschungsgemeinschaft (German Research Foundation) EXC 2151-390873048EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020) 101016167
6 · The paper itself

Abstract

Post-Acute Infectious Syndromes (PAIS) refer to the symptoms persisting months after initial infection. Clinical research studies on this topic often collect rich, multi-modal datasets. Yet, the complexity of the datasets and the lack of a precise clinical case definition pose difficulties in creating comprehensive analyses. Here, we present a generalisable framework for analysing data from longitudinal studies of PAIS using Latent Transition Analysis (LTA). It enables the identification of disease phenotypes and the patient-level analysis of transitions between them, without relying on predefined clinical categorisations. Furthermore, we introduce a method for incorporating covariate information, which enables exploration of how patient characteristics influence disease trajectories. We apply this methodology to the ORCHESTRA dataset, composed of individuals affected by SARS-CoV-2 infection from multiple European centres, for investigation into Post-COVID-19 condition (PCC). 5094 patient assessments were collected at SARS-CoV-2 infection, and at 6, 12, 18, and 24 months of follow-up. Our model identifies distinct PCC phenotypes with patient trajectories impacted by age and sex. Our results highlight how LTA can enhance the interpretability of complex, time-resolved clinical data, support personalized patient monitoring and management, and accelerate therapeutic development for other PAISs, too.

Indexed as

COVID-19AdultAgedFemaleHumansLongitudinal StudiesMaleMiddle AgedPhenotypePost-Acute COVID-19 SyndromeSARS-CoV-2

Identifiers

PMID41667444
PMCPMC13000239

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.